Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started 

  • (+01) 512 835 8026
  • Email Us
Get a Quote Contact | FAQ's | Blog
Rules-Based Medicine Rules-Based Medicine

a Q<sup>2</sup> Solutions Company

Toggle menu

Skip to content
  • About Us
    • About RBM

      Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.
    • About RBM

      • About Us
      • Our Scientists
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications
    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog
    • Data Quality

      • Overview
      • RBM Technology
  • Biomarker Solutions
    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • NEW! Idiopathic Pulmonary Fibrosis (IPF) Biomarkers
      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support
    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools
    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order
    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions
    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist
    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

Category Archives: Cardiac

17 Aug 2018
Quality Control worksheet

Cytokines, Hemodynamic Parameters, & Clinical Outcomes in PAH

August 17, 2018
Rules-Based Medicine
Cardiac, Cytokines and Chemokines, Inflammation
Aditya A. Joshi, Ryan Davey, Youlan Rao, Kai Shen, Raymond L. Benza, Amresh Raina Read Full Article » Pulmonary arterial hypertension (PAH) is a r...
Read More
9 May 2017

Blood Based Biomarker Test to Predict Major Cardiac Events

May 9, 2017
Rules-Based Medicine
Blog, Cardiac, Utilized Rules-Based Medicine's Services
Prevencio, Inc. has announced data published in The American Journal of Cardiology, on a new proteomic blood test that determines whether a person wil...
Read More
19 Nov 2015

Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia

November 19, 2015
Rules-Based Medicine
Cardiac, Diabetes, Utilized Rules-Based Medicine's Services
An international team of researchers used Myriad RBM’s Multi-Analyte Profile (MAP) technology to identify a pattern of cardiometabolic biomarkers that...
Read More
31 Oct 2014

ENRAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease

October 31, 2014
Rules-Based Medicine
Cardiac, Inflammation, Utilized Rules-Based Medicine's Services
This recent paper in the Arteriosclerosis, Thrombosis and Vascular Biology Journal of the American Heart Association describes an interesting prospect...
Read More
7 Aug 2014

Biomarkers enhance prediction of cardiovascular events when added to clinical risk factors in the ORIGIN trial

August 7, 2014
Rules-Based Medicine
Blog, Cardiac, Utilized Rules-Based Medicine's Services
Measuring large numbers of biomarkers in blood with new assay technologies may identify new biomarkers and physiologic pathways for cardiovascular eve...
Read More
27 Feb 2014

New Biomarker Offers Hope for Early Detection of Cardiac Injury

February 27, 2014
Rules-Based Medicine
Blog, Cardiac
Myocardial infarctions and acute coronary syndrome affect nearly 1 million Americans every year. These events result in damage to the heart tissue and...
Read More
23 May 2013

Blood Protein May Contribute to Early Development of Atherosclerosis

May 23, 2013
Rules-Based Medicine
Blog, Cardiac
A study conducted by Dr. Eric Thorin of the Montreal Heart Institute, suggests blood levels of angiopoietin-like protein 2 (angptl2) may represent an...
Read More
1 2

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Rules-Based Medicine's Services (43)

ABOUT RBM

Overview
Our Scientists
Quality Policy
Employment
Partners
Sales Team
Certifications

A Q2 Solutions Company

Contact Us

Q2 Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2023 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information